ResMed Inc. (RMD:NYSE) closed at $253.20 on October 26, 2026, up 0.13% on the day. The stock trades 8.8% below its 52-week high of $277.67 and 40.5% above its 52-week low of $180.27. Over the past year, it lost 2.6%. ResMed Inc. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since October 24, 2025, RMD closed higher on 129 days (51%). Its best day was August 19, 2026 (+4.85%) and its worst was July 8, 2026 (-6.33%). It never moved 10% or more in a single session.
ResMed Inc. designs, develops, manufactures, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders. Its portfolio of products include devices, such as air flow generators, ventilators, and oxygen concentrators; diagnostic products; mask systems; headgear and other accessories; dental devices; portable oxygen concentrators; and cloud-based software informatics solutions. The company also produces continuous positive airway pressure, variable positive airway pressure, and AutoSet systems for the titration and treatment of sleep disordered breathing (SDB). In addition, it offers data communications and control products, such as EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 100 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Find more stocks like RMD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.